Cervical cancer risk factors among HIV-infected Nigerian women

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Ononogbu, Uzoma ^a   Almujtaba, Maryam ^b   Modibbo, Fatima ^c   Lawal, Ishak ^d   Offiong, Richard ^d   Olaniyan, Olayinka ^c   Dakum, Patrick ^b   Spiegelman, Donna ^a   Blattner, William ^e   Adebamowo, Clement ^b,e  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b INSTITUTE OF HUMAN VIROLOGY NIGERIA   (Nigeria)

^c NATIONAL HOSPITAL   (Nigeria)

^d UNIVERSITY OF ABUJA   (Nigeria)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical cancer; HIV; Screen and treat; VIA VILI

Indexed keywords

ADULT; ARTICLE; BINOMIAL DISTRIBUTION; COMORBIDITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MASS SCREENING; MIDDLE AGED; NIGERIA; PREVALENCE; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

ADULT; BINOMIAL DISTRIBUTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; COMORBIDITY; FEMALE; HIV INFECTIONS; HUMANS; MASS SCREENING; MIDDLE AGED; NIGERIA; PREVALENCE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84878894257     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-582     Document Type: Article

References (53)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet] Lyon, France: International Agency for Research on Cancer 2010
2. HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data. Mbulaiteye SM, Bhatia K, Adebamowo C, Sasco AJ, Infectious Agents and Cancer 2011 6 1 16 10.1186/1750-9378-6-16 22004990
3. Cancer incidence in Nigeria: A report from population-based cancer registries. Jedy-Agba E, Curado MP, Ogunbiyi O, Oga E, Fabowale T, Igbinoba F, Osubor G, Otu T, Kumai H, Koechlin A, Cancer Epidemiology 2012 36 5 271 e278 10.1016/j.canep.2012.04.007 22621842
4. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S, Br J Cancer 2003 88 1 63 73 10.1038/sj.bjc.6600688 12556961 (Pubitemid 36241220)
5. Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa. Vuyst HD, Ndirangu G, Moodley M, Tenet V, Estambale B, Meijer CJ, Snijders PJ, Clifford G, Franceschi S, International journal of cancer Journal international du cancer 2012 131 4 949 955 10.1002/ijc.26470 21960453
6. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, et al. J Natl Cancer Inst 2006 98 5 303 315 10.1093/jnci/djj067 16507827 (Pubitemid 43338210)
7. Chapter 3: Cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. Castellsague X, Munoz N, Journal of the National Cancer Institute Monographs 2003 31 31 20 28 12807941
8. The global burden of cancer: priorities for prevention. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM, Carcinogenesis 2010 31 1 100 110 10.1093/carcin/bgp263 19934210
9. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. Frisch M, Biggar RJ, Goedert JJ, J Natl Cancer Inst 2000 92 18 1500 1510 10.1093/jnci/92.18.1500 10995805
10. Cervical cancer prevention in HIV-infected women in resource-limited settings. Parham G, HIV Therapy 2010 4 6 625 628 10.2217/hiv.10.58
11. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. De Vuyst H, Lillo F, Broutet N, Smith JS, Eur J Cancer Prev 2008 17 6 545 554 10.1097/CEJ.0b013e3282f75ea1 18941376
12. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, Wright TC Jr, JAMA 2000 283 8 1031 1037 10.1001/jama.283.8.1031 10697063 (Pubitemid 30112217)
13. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, Safaeian M, Astemborski J, Daniel R, Shah K, J Infect Dis 2001 184 6 682 690 10.1086/323081 11517428 (Pubitemid 32826418)
14. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. Ic HIV, Coutinho RA, J Natl Cancer Inst 2000 92 15 1823 1830 11078759
15. Prevention of cervical cancer in women with HIV. Heard I, Curr Opin HIV AIDS 2009 4 1 68 73 10.1097/COH.0b013e328319bcbe 19339941
16. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C, Mkumba G, Mudenda V, Hicks ML, Vermund SH, Stringer JS, et al. PLoS Med 2011 8 5 1001032 10.1371/journal.pmed.1001032 21610859
17. AIDS-related cancer and severity of immunosuppression in persons with AIDS. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA, J Natl Cancer Inst 2007 99 12 962 972 10.1093/jnci/djm010 17565153 (Pubitemid 47073502)
18. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, J Natl Cancer Inst 2005 97 6 425 432 10.1093/jnci/dji072 15770006 (Pubitemid 40528605)
19. Chapter 8: Screening for cervical cancer in developing countries. Denny L, Quinn M, Sankaranarayanan R, Vaccine 2006 24 3 71 77
20. The role of hospital-based cancer registries in low and middle income countries-The Nigerian Case Study. Jedy-Agba EE, Curado MP, Oga E, Samaila MO, Ezeome ER, Obiorah C, Erinomo OO, Ekanem IA, Uka C, Mayun A, Cancer Epidemiol 2012 36 5 430 435 10.1016/j.canep.2012.05.010 22704971
21. Accuracy of visual inspection with acetic acid for cervical cancer screening. Sauvaget C, Fayette JM, Muwonge R, Wesley R, Sankaranarayanan R, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2011 113 1 14 24 10.1016/j.ijgo.2010.10.012
22. Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH, Cancer Prev Res (Phila) 2012 5 1 11 17 10.1158/1940-6207.CAPR-11-0540
23. Screening Tests. IARC, Cervix Cancer Screening. Volume 10 Lyon, France: IARC 2005 59 109
24. Sankaranarayanan R, Wesley RS, A practical manual on visual screening for cervical neoplasia Lyon, France: IARC Press 2003 [IARC Technical Publication No. 41]
25. Easy SAS calculations for risk or prevalence ratios and differences. Spiegelman D, Hertzmark E, Am J Epidemiol 2005 162 3 199 200 10.1093/aje/kwi188 15987728 (Pubitemid 41373523)
26. Binomial regression in GLIM: estimating risk ratios and risk differences. Wacholder S, Am J Epidemiol 1986 123 1 174 184 3509965 (Pubitemid 16189710)
27. Simulation study of confounder-selection strategies. Maldonado G, Greenland S, Am J Epidemiol 1993 138 11 923 936 8256780 (Pubitemid 24002359)
28. Flexible regression models with cubic splines. Durrleman S, Simon R, Stat Med 2006 8 5 551 561
29. Comparing smoothing techniques in Cox models for exposure-response relationships. Govindarajulu US, Spiegelman D, Thurston SW, Ganguli B, Eisen EA, Stat Med 2007 26 20 3735 3752 10.1002/sim.2848 17538974 (Pubitemid 47307746)
30. World Health Organization, Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance: African region Geneva, Switzerland: World Health Organization 2005
31. Cervical dysplasia and HIV type 1 infection in African pregnant women: a cross sectional study, Kigali, Rwanda. The Pregnancy and HIV Study Group (EGE). Leroy V, Ladner J, De Clercq A, Meheus A, Nyiraziraje M, Karita E, Dabis F, Sex Transm Infect 1999 75 2 103 106 10.1136/sti.75.2.103 10448362 (Pubitemid 29236999)
32. Prevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings. Memiah P, Mbuthia W, Kiiru G, Agbor S, Odhiambo F, Ojoo S, Biadgilign S, AIDS research and treatment 2012 2012 953743 22548156
33. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study. Moodley J, Constant D, Hoffman M, Salimo A, Allan B, BMC Cancer 2009 9 1 275 10.1186/1471-2407-9-275 19664216
34. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. Blossom DB, Beigi RH, Farrell JJ, Mackay W, Qadadri B, Brown DR, Rwambuya S, Walker CJ, Kambugu FS, Abdul-Karim FW, J Med Virol 2007 79 6 758 765 10.1002/jmv.20817 17457908 (Pubitemid 46709371)
35. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH, Gynecol Oncol 2006 103 3 1017 1022 10.1016/j.ygyno.2006.06.015 16875716 (Pubitemid 44830069)
36. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. Hawes SE, Critchlow CW, Niang MAF, Diouf MB, Diop A, Toure P, Kasse AA, Dembele B, Sow PS, Coll-Seck AM, J Infect Dis 2003 188 4 555 563 10.1086/376996 12898443 (Pubitemid 37011808)
37. HPV infection in women with and without cervical cancer in Conakry, Guinea. Keita N, Clifford GM, Koulibaly M, Douno K, Kabba I, Haba M, Sylla BS, Van Kemenade FJ, Snijders PJF, Meijer C, Br J Cancer 2009 101 1 202 208 10.1038/sj.bjc.6605140 19536089
38. The status of cervical cytology in Swaziland, Southern Africa: a descriptive study. Okonda S, Wright C, Michelow P, Cytojournal 2009 6 1 14 10.4103/1742-6413.54916 19826481
39. Summary of informal discussion on general aspects of cervical cancer. Wilbanks GD, Cancer Res 1973 33 6 1382 1384 4718681
40. Rothman K, Greenland S, Modern Epidemiology, 2nd edn Boston, MA: Lippincott, Williams and Wilkins 1998
41. Cervical cancer screening by visual inspection in Cote d'Ivoire, operational and clinical aspects according to HIV status. Horo A, Jaquet A, Ekouevi DK, Toure B, Coffie PA, Effi B, Messou E, Minga A, Moh R, Kone M, BMC Public Health 2012 12 1 237 10.1186/1471-2458-12-237 22443255
42. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. Weinhardt LS, Carey MP, Johnson BT, Bickham NL, Am J Public Health 1999 89 9 1397 1405 10.2105/AJPH.89.9.1397 10474559 (Pubitemid 29404565)
43. Human Papillomavirus Infection and Cervical Cytology in HIVInfected and HIVUninfected Rwandan Women. Singh DK, Anastos K, Hoover DR, Burk RD, Shi Q, Ngendahayo L, Mutimura E, Cajigas A, Bigirimani V, Cai X, Rwamwejo J, Vuolo M, Cohen M, Castle PE, J Infect Dis 2009 199 12 1851 1861 10.1086/599123 19435429
44. Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women. Anastos K, Hoover DR, Burk RD, Cajigas A, Shi Q, Singh DK, Cohen MH, Mutimura E, Sturgis C, Banzhaf WC, Castle PE, PLoS One 2010 5 10 13525 10.1371/journal.pone.0013525 20976000
45. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, Holmberg SD, Brooks JT, Ann Intern Med 2008 148 10 728 736 10.7326/0003-4819-148-10-200805200-00005 18490686 (Pubitemid 351717418)
46. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, Falcini F, Russo A, Intrieri T, Vercelli M, Zambon P, Br J Cancer 2009 100 5 840 847 10.1038/sj.bjc.6604923 19223894
47. Cervical cancer screening and prevention for HIV-infected women in the developing world. Anderson J, Lu E, Sanghvi H, Kibwana S, Lu A, Mol Biosyst 2010 6 1162 1172 10.1039/b923958h 20436967
48. US Cancer Statistics Working Group, United States Cancer Statistics: 1999-2007 Incidence and Mortality Web-based Report Atlanta GA US Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute. 2010 23754527
49. Impact of HIV infection on invasive cervical cancer in Kenyan women. Gichangi PB, Bwayo J, Estambale B, De Vuyst H, Ojwang S, Rogo K, Abwao H, Temmerman M, AIDS 2003 17 13 1963 1968 10.1097/00002030-200309050-00015 12960829 (Pubitemid 37070282)
50. Invasive cervical cancer and human immunodeficiency virus (HIV) infection: a South African perspective. Moodley M, Moodley J, Kleinschmidt I, Int J Gynecol Cancer 2001 11 3 194 197 10.1046/j.1525-1438.2001.01022.x 11437924 (Pubitemid 32622665)
51. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. Harris TG, Burk RD, Palefsky JM, Massad LS, Bang JY, Anastos K, Minkoff H, Hall CB, Bacon MC, Levine AM, JAMA 2005 293 12 1471 1476 10.1001/jama.293.12.1471 15784870 (Pubitemid 40393291)
52. CD4 T-Cell count, viral load, and squamous intraepithelial lesions in women infected with the human immunodeficiency virus. Cardillo M, Hagan R, Abadi J, Abadi MA, Cancer Cytopathol 2001 93 2 111 114 10.1002/cncr.9016 (Pubitemid 32322165)
53. The epidemiology of cervical carcinogenesis. Schiffman MH, Brinton LA, Cancer 2006 76 S10 1888 1901